Iron flow battery patents cluster around a different set of technical problems than vanadium systems, chiefly hydrogen evolution at the negative electrode, uneven iron plating, and electrolyte cost control, all of which show up directly in the search terms behind this dataset. Vanadium chemistry claims tend to focus more on membrane crossover and vanadium oxidation-state stability. Because iron is cheaper and more abundant than vanadium, much of the claim language here is explicitly framed around cost reduction and operating-window control rather than raw energy density. All 37 records in this dataset classify under the same H01M subclass as vanadium flow patents, so the two chemistries compete for adjacent, sometimes overlapping, claim space.

The ranked list in this dataset covers 14 assignees, with the leading company holding 11 of the 37 records in scope, close to a third of the field by itself. The top 5 assignees together hold 75.7% of all records, and the top 10 hold 91.9%, meaning the vast majority of protected claim space sits with a small group rather than being spread across many independent filers. Chinese research institutions filing on iron and zinc-iron electrolyte chemistry appear repeatedly in the ranked list alongside commercial flow-battery developers. Anyone assessing competitive risk in this space should start with that concentrated group rather than scanning broadly.

Filing activity peaked at 10 records in 2023, but the 2022 midpoint of 6 shows the growth curve had already begun levelling before that peak, and several leading assignees recorded zero filings in the most recent tracked year. Because patent publication typically lags actual filing by around 18 months, the final year or two in any dataset understates true activity, so the field may be less quiet than the raw numbers suggest. Even accounting for that lag, the pattern across 2022-2023 reads as a plateau rather than an accelerating trend. Anyone tracking this space should expect revisions to recent-year figures as more filings publish.

The technology composition data shows every record in this dataset falls under a single IPC subclass, H01M, meaning the field's real differentiation happens inside claim language rather than across separate technology domains. Sub-areas built into the underlying search terms but showing thinner density in the corpus include hydrogen evolution suppression additives, plating uniformity control methods, and complexing-agent chemistries beyond EDTA and its direct analogues. The representative 2024 filing from Dalian Institute of Chemical Physics, for example, claims a specific 1:1 zinc-to-complexing-agent ratio, which by its narrowness suggests other stoichiometric ranges or alternative complexing agents remain unclaimed. A proper whitespace assessment would still need a full claim map rather than relying on search-term coverage alone.

China is the dominant receiving office in this dataset with 18 of the 37 records, roughly half the total, ahead of WIPO's PCT route with 6, Europe with 5, and Australia and the United States tied at 3 each, with India at 2. That skew means a competitive or freedom-to-operate review limited to US or European patent offices would miss the majority of documented activity in this specific chemistry space. It also suggests that Chinese research institutions and companies are treating this as a priority filing jurisdiction well ahead of Western counterparts. Anyone building monitoring alerts for this field should include China's patent office as a primary source, not a supplementary one.